Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 736752, 9 pages
http://dx.doi.org/10.1155/2012/736752
Research Article

Beneficial Effects of Ocimum gratissimum Aqueous Extract on Rats with CCl4-Induced Acute Liver Injury

1Institute of Microbiology and Immunology, Chung Shan Medical University, Taichung 40201, Taiwan
2Department of Neurology and Department of Medical Intensive Care Unit, Chunghua Christian Hospital, Chunghua 500, Taiwan
3Graduate Institute of Chinese Medical Science, China Medical University, Taichung 40402, Taiwan
4Institute of Basic Medical Science, China Medical University, Taichung 40402, Taiwan
5Department of Health and Nutrition Biotechnology, Asia University, Taichung 41354, Taiwan
6Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
7Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
8Institute of Biochemistry and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan
9Clinical Laboratory, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
10Center for Molecular Medicine, China Medical University Hospital, Taichung 40402, Taiwan
11Department of Biochemistry, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan

Received 9 March 2012; Revised 9 April 2012; Accepted 24 April 2012

Academic Editor: Hong Zhang

Copyright © 2012 Chun-Ching Chiu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Vernon, A. Baranova, and Z. M. Younossi, “Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults,” Alimentary Pharmacology and Therapeutics, vol. 34, no. 3, pp. 274–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Grünhage, H. P. Fischer, T. Sauerbruch, and C. Reichel, “Drug- and toxin-induced hepatotoxicity,” Zeitschrift fur Gastroenterologie, vol. 41, no. 6, pp. 565–578, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. P. R. S. Kodavanti, U. M. Joshi, R. A. Young, E. F. Meydrech, and H. M. Mehendale, “Protection of hepatotoxic and lethal effects of CCl4 by partial hepatectomy,” Toxicologic Pathology, vol. 17, no. 3, pp. 494–505, 1989. View at Google Scholar · View at Scopus
  4. S. A. Sheweita, M. Abd El-Gabar, and M. Bastawy, “Carbon tetrachloride-induced changes in the activity of phase II drug-metabolizing enzyme in the liver of male rats: role of antioxidants,” Toxicology, vol. 165, no. 2-3, pp. 217–224, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. V. E. de Meijer, D. Y. Sverdlov, Y. Popov et al., “Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice,” PLoS ONE, vol. 5, no. 6, Article ID e11256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Quan, L. Piao, H. Xu, T. Li, and X. Yin, “Protective effect of iridoid glucosides from Boschniakia rossica on acute liver injury induced by carbon tetrachloride in rats,” Bioscience, Biotechnology and Biochemistry, vol. 73, no. 4, pp. 849–854, 2009. View at Publisher · View at Google Scholar
  7. M. H. Tang, P. Y. Chiu, and K. M. Ko, “Hepatoprotective action of schisandrin B against carbon tetrachloride toxicity was mediated by both enhancement of mitochondrial glutathione status and induction of heat shock proteins in mice,” BioFactors, vol. 19, no. 1-2, pp. 33–42, 2003. View at Google Scholar · View at Scopus
  8. F. Stickel and D. Schuppan, “Herbal medicine in the treatment of liver diseases,” Digestive and Liver Disease, vol. 39, no. 4, pp. 293–304, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Prakash and N. Gupta, “Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: a short review,” Indian Journal of Physiology and Pharmacology, vol. 49, no. 2, pp. 125–131, 2005. View at Google Scholar · View at Scopus
  10. F. D. Onajobi, “Smooth muscle contracting lipid-soluble principles in chromatographic fractions of Ocimum gratissimum,” Journal of Ethnopharmacology, vol. 18, no. 1, pp. 3–11, 1986. View at Google Scholar · View at Scopus
  11. J. Prakash and S. K. Gupta, “Chemopreventive activity of Ocimum sanctum seed oil,” Journal of Ethnopharmacology, vol. 72, no. 1-2, pp. 29–34, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. S. K. Gupta, J. Prakash, and S. Srivastava, “Validation of traditional claim of Tulsi, Ocimum sanctum Linn. as a medicinal plant,” Indian Journal of Experimental Biology, vol. 40, no. 7, pp. 765–773, 2002. View at Google Scholar · View at Scopus
  13. O. M. Ighodaro and O. A. Ebuehi, “Aqueous leaf extract of Ocimum gratissimum potentiates activities of plasma and hepatic antioxidant enzymes in rats,” Nigerian Quarterly Journal of Hospital Medicine, vol. 19, no. 2, pp. 106–109, 2009. View at Google Scholar · View at Scopus
  14. M. J. Lee, H. M. Chen, B. S. Tzang et al., “Ocimum gratissimum aqueous extract protects H9c2 myocardiac cells from H2O2-induced cell apoptosis through akt signalling,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 578060, 8 pages, 2011. View at Publisher · View at Google Scholar
  15. R. Prashar, A. Kumar, S. Banerjee, and A. R. Rao, “Chemopreventive action by an extract from Ocimum sanctum on mouse skin papillomagenesis and its enhancement of skin glutathione S-transferase activity and acid soluble sulfhydryl level,” Anti-Cancer Drugs, vol. 5, no. 5, pp. 567–572, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Karthikeyan, P. Ravichandran, and S. Govindasamy, “Chemopreventive effect of Ocimum sanctum on DMBA-induced hamster buccal pouch carcinogenesis,” Oral Oncology, vol. 35, no. 1, pp. 112–119, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. H.-M. Chen, M.-J. Lee, S.-H. Kao, C.-Y. Kuo, P.-L. Tsai, and J.-Y. Liu, “Ocimum gratissimum aqueous extract induces apoptotic signalling in lung adenocarcinoma cell A549,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 739093, 7 pages, 2011. View at Publisher · View at Google Scholar
  18. P. S. Rao, R. S. Mangipudy, and H. M. Mehendale, “Tissue injury and repair as parallel and opposing responses to CCl4 hepatotoxicity: a novel dose-response,” Toxicology, vol. 118, no. 2-3, pp. 181–193, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Cos, P. Rajan, I. Vedernikova et al., “In vitro antioxidant profile of phenolic acid derivatives,” Free Radical Research, vol. 36, no. 6, pp. 711–716, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. T. C. Hsu, S. Y. Chiang, C. Y. Huang et al., “Beneficial effects of treatment with transglutaminase inhibitor cystamine on macrophage response in NZB/W F1 mice,” Experimental Biology and Medicine, vol. 232, no. 2, pp. 195–203, 2007. View at Google Scholar · View at Scopus
  21. P. Abraham, G. Wilfred, and S. P. Cathrine, “Oxidative damage to the lipids and proteins of the lungs, testis and kidney of rats during carbon tetrachloride intoxication,” Clinica Chimica Acta, vol. 289, no. 1-2, pp. 177–179, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Szymonik-Lesiuk, G. Czechowska, M. Stryjecka-Zimmer et al., “Catalase, superoxide dismutase, and glutathione peroxidase activities in various rat tissues after carbon tetrachloride intoxication,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 10, no. 4, pp. 309–315, 2003. View at Publisher · View at Google Scholar
  23. L. W. D. Weber, M. Boll, and A. Stampfl, “Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model,” Critical Reviews in Toxicology, vol. 33, no. 2, pp. 105–136, 2003. View at Google Scholar · View at Scopus
  24. R. O. Recknagel, “Carbon tetrachloride hepatotoxicity: status quo and future prospects,” Trends in Pharmacological Sciences C, vol. 4, pp. 129–131, 1983. View at Google Scholar · View at Scopus
  25. T. Takami, S. Terai, and I. Sakaida, “Novel findings for the development of drug therapy for various liver diseases: current state and future prospects for our liver regeneration therapy using autologous bone marrow cells for decompensated liver cirrhosis patients,” Journal of Pharmacological Sciences, vol. 115, no. 3, pp. 274–278, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. M. Manicone and J. K. McGuire, “Matrix metalloproteinases as modulators of inflammation,” Seminars in Cell and Developmental Biology, vol. 19, no. 1, pp. 34–41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. P. Iredale, “Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ,” Journal of Clinical Investigation, vol. 117, no. 3, pp. 539–548, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. St-Pierre, J. Couillard, and C. Van Themsche, “Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases,” Expert Opinion on Therapeutic Targets, vol. 8, no. 5, pp. 473–489, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Li, G. K. K. Lau, L. Chen et al., “Interleukin 17a promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression,” PLoS ONE, vol. 6, no. 7, Article ID e21816, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Knittel, M. Mehde, A. Grundmann, B. Saile, J. G. Scharf, and G. Ramadori, “Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat,” Histochemistry and Cell Biology, vol. 113, no. 6, pp. 443–453, 2000. View at Google Scholar · View at Scopus
  31. O. Kollet, S. Shivtiel, Y. Q. Chen et al., “HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34 + stem cell recruitment to the liver,” Journal of Clinical Investigation, vol. 112, no. 2, pp. 160–169, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. C. von Montfort, J. I. Beier, J. P. Kaiser et al., “PAI-1 plays a protective role in CCl4-induced hepatic fibrosis in mice: role of hepatocyte division,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 298, no. 5, pp. G657–G666, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. G.-J. Huang, J.-S. Deng, C.-S. Chiu et al., “Hispolon protects against acute liver damage in the rat by inhibiting lipid peroxidation, proinflammatory cytokine, and oxidative stress and downregulating the expressions of iNOS, COX-2, and MMP-9,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 480714, 12 pages, 2012. View at Publisher · View at Google Scholar
  34. M. Menshikov, E. Elizarova, K. Plakida et al., “Urokinase upregulates matrix metalloproteinase-9 expression in THP-1 monocytes via gene transcription and protein synthesis,” Biochemical Journal, vol. 367, no. 3, pp. 833–839, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Burggraf, H. K. Martens, M. Dichgans, and G. F. Hamann, “Matrix metalloproteinase (MMP) induction and inhibition at different doses of recombinant tissue plasminogen activator following experimental stroke,” Thrombosis and Haemostasis, vol. 98, no. 5, pp. 963–969, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Liu and M. J. Wilson, “miR-520c and miR-373 target mTOR and SIRT1, activate the Ras/Raf/MEK/Erk pathway and NF-κB, with up-regulation of MMP9 in human fibrosarcoma cells,” Journal of Cellular Physiology, vol. 227, no. 2, pp. 867–876, 2012. View at Google Scholar
  37. M. Rajadurai and P. Stanely Mainzen Prince, “Preventive effect of naringin on lipid peroxides and antioxidants in isoproterenol-induced cardiotoxicity in Wistar rats: biochemical and histopathological evidences,” Toxicology, vol. 228, no. 2-3, pp. 259–268, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. F. A. Crocenzi and M. G. Roma, “Silymarin as a new hepatoprotective agent in experimental cholestasis: new possibilities for an ancient medication,” Current Medicinal Chemistry, vol. 13, no. 9, pp. 1055–1074, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. J. H. Tsai, J. Y. Liu, T. T. Wu et al., “Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats,” Journal of Viral Hepatitis, vol. 15, no. 7, pp. 508–514, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. L. A. Giese, “Milk thistle and the treatment of hepatitis,” Gastroenterology Nursing, vol. 24, no. 2, pp. 95–97, 2001. View at Google Scholar · View at Scopus